-
公开(公告)号:HUT75554A
公开(公告)日:1997-05-28
申请号:HU9601298
申请日:1994-11-10
Applicant: BASF AG
Inventor: HILLEN HEINZ , JACOB ELARD , KROEGER BURKHARD , MEYER THOMAS , OTTER RAINER , SCHMIDT MARTIN , SEULBERGER HARALD , SUBKOWSKI THOMAS
IPC: G01N33/573 , A01K67/027 , A61K31/70 , A61K35/12 , A61K38/00 , A61K38/43 , A61K38/48 , A61K39/395 , A61K48/00 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/00 , A61P13/02 , A61P15/00 , A61P25/04 , A61P25/28 , A61P29/00 , A61P31/04 , C07H21/04 , C07K14/47 , C07K16/40 , C12N5/00 , C12N5/10 , C12N9/64 , C12N15/09 , C12N15/113 , C12N15/57 , C12R1/91 , C12N15/11
Abstract: PCT No. PCT/EP94/03706 Sec. 371 Date May 16, 1996 Sec. 102(e) Date May 16, 1996 PCT Filed Nov. 10, 1994 PCT Pub. No. WO95/14095 PCT Pub. Date May 26, 1995The invention relates to endothelin-converting enzymes containing the polypeptide sequence described in SEQ. ID. NO. 30 or SEQ. ID. NO. 36 or functional fragments thereof, genes which code for such enzymes, and processes for producing the said enzymes and the use thereof.
-
公开(公告)号:DE59208025D1
公开(公告)日:1997-03-20
申请号:DE59208025
申请日:1992-11-19
Applicant: BASF AG
Inventor: STRUBE KARL-HERMANN , BIALOJAN SIEGFRIED , KROEGER BURKHARD , FRIEDRICH THOMAS
IPC: A61K38/55 , A61K38/00 , A61P7/02 , C07K14/00 , C07K14/435 , C07K14/81 , C07K14/815 , C12N15/09 , C12N15/15 , C12P21/02 , C12R1/19
Abstract: PCT No. PCT/EP92/02661 Sec. 371 Date May 18, 1994 Sec. 102(e) Date May 18, 1994 PCT Filed Nov. 19, 1992 PCT Pub. No. WO93/11239 PCT Pub. Date Oct. 6, 1993.Novel thrombin-inhibitory proteins from terrestrial leeches of the genus Haemadipsa with the amino-acid sequence Ile-Arg-Phe-Gly-Met-Gly-Lys-Val-Pro-Cys-Pro-Asp-Gly-Glu-Val-Gly-Tyr-Thr-Cys-Asp-Cys-Gly-Glu-Lys-Ile-Cys-Leu-Tyr-Gly-Gln-Ser-Cys-Asn-Asp-Gly-Gln-Cys-Ser-Gly-Asp-Pro-Lys-Pro-Ser-Ser-Glu-Phe-Glu-Glu-Phe-Glu-Ile-Asp-Glu-Glu-Glu-Lys, or an amino-acid sequence which is obtained by C-terminal truncation of this sequence by from one to twelve amino acids, are described. The proteins are suitable for controlling diseases. Also described are the nucleic acids coding for these proteins.
-
公开(公告)号:SI9520048A
公开(公告)日:1997-02-28
申请号:SI9520048
申请日:1995-03-23
Applicant: BASF AG
Inventor: BAUMANN ERNST , VOGELBACHER UWE JOSEF , RHEINHEIMER JOACHIM , KLINGE DAGMAR , RIECHERS HARTMUT , KROEGER BURKHARD , BIALOJAN SIEGFRIED , BOLLSCHWEILER CLAUS , WERNET WOLFGANG , UNGER LILIANE , RASCHACK MANFRED
IPC: A61K31/00 , A61K31/505 , A61K31/506 , C07D251/26 , A61K31/53 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , A61P39/02 , C07D239/26 , C07D239/34 , C07D239/38 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I I
-
公开(公告)号:FI963885A0
公开(公告)日:1996-09-27
申请号:FI963885
申请日:1996-09-27
Applicant: BASF AG
Inventor: BAUMANN ERNST , VOGELBACHER UWE JOSEF , RHEINHEIMER JOACHIM , KLINGE DAGMAR , RIECHERS HARTMUT , KROEGER BURKHARD , BIALOJAN SIEGFRIED , BOLLSCHWEILER CLAUS , WERNET WOLFGANG , UNGER LILIANE , RASCHACK MANFRED
IPC: C07D251/26 , A61K31/00 , A61K31/505 , A61K31/506 , A61K31/53 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , A61P39/02 , C07D239/26 , C07D239/34 , C07D239/38 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , A61K
Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I I
-
公开(公告)号:PL314480A1
公开(公告)日:1996-09-16
申请号:PL31448094
申请日:1994-11-10
Applicant: BASF AG
Inventor: KROEGER BURKHARD , SEULBERGER HARALD , MEYER THOMAS , SCHMIDT MARTIN , JACOB ELARD , OTTER RAINER , SUBKOWSKI THOMAS , HILLEN HEINZ
IPC: G01N33/573 , A01K67/027 , A61K31/70 , A61K35/12 , A61K38/00 , A61K38/43 , A61K38/48 , A61K39/395 , A61K48/00 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/00 , A61P13/02 , A61P15/00 , A61P25/04 , A61P25/28 , A61P29/00 , A61P31/04 , C07H21/04 , C07K14/47 , C07K16/40 , C12N5/00 , C12N5/10 , C12N9/64 , C12N15/09 , C12N15/113 , C12N15/57 , C12R1/91
Abstract: PCT No. PCT/EP94/03706 Sec. 371 Date May 16, 1996 Sec. 102(e) Date May 16, 1996 PCT Filed Nov. 10, 1994 PCT Pub. No. WO95/14095 PCT Pub. Date May 26, 1995The invention relates to endothelin-converting enzymes containing the polypeptide sequence described in SEQ. ID. NO. 30 or SEQ. ID. NO. 36 or functional fragments thereof, genes which code for such enzymes, and processes for producing the said enzymes and the use thereof.
-
公开(公告)号:CA2176507A1
公开(公告)日:1995-05-26
申请号:CA2176507
申请日:1994-11-10
Applicant: BASF AG
Inventor: KROEGER BURKHARD , SEULBERGER HARALD , MEYER THOMAS , SCHMIDT MARTIN , JACOB ELARD , OTTER RAINER , SUBKOWSKI THOMAS , HILLEN HEINZ
IPC: G01N33/573 , A01K67/027 , A61K31/70 , A61K35/12 , A61K38/00 , A61K38/43 , A61K38/48 , A61K39/395 , A61K48/00 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/00 , A61P13/02 , A61P15/00 , A61P25/04 , A61P25/28 , A61P29/00 , A61P31/04 , C07H21/04 , C07K14/47 , C07K16/40 , C12N5/00 , C12N5/10 , C12N9/64 , C12N15/09 , C12N15/113 , C12N15/57 , C12R1/91 , C12Q1/37
Abstract: The invention relates to endothelin-converting enzymes containing the polypeptide sequence described in SEQ. ID. NO. 30 or SEQ. ID. NO. 36 or functional fragments thereof, genes which code for such enzymes, and processes for producing the said enzymes and the use thereof.
-
公开(公告)号:CA2121352A1
公开(公告)日:1993-05-13
申请号:CA2121352
申请日:1992-10-27
Applicant: BASF AG
Inventor: FRIEDRICH THOMAS , BIALOJAN SIEGFRIED , KROEGER BURKHARD , KUENAST CHRISTOPH
IPC: A61K35/64 , A61K38/00 , A61K38/55 , A61P7/02 , C07K14/00 , C07K14/245 , C07K14/435 , C07K14/81 , C12N15/15 , C12P21/02 , C12R1/19 , A61K38/57
Abstract: 2121352 9309232 PCTABS00022 The description relates to a novel thrombin inhibiting protein from reduvii with a molecular weight of some 12000 Dalton and the N-terminus Glu-Gly-Gly-Glu-Pro-Cys-Ala-Cys-Pro-His-Ala-Leu-His-Arg-Val-Cys-Gly-Ser-Asp. The protein is useful in combatting diseases.
-
公开(公告)号:CA2121246A1
公开(公告)日:1993-05-13
申请号:CA2121246
申请日:1992-09-23
Applicant: BASF AG
Inventor: FRIEDRICH THOMAS , KOERWER WOLFGANG , KROEGER BURKHARD , BIALOJAN SIEGFRIED
IPC: A61K35/64 , A61K38/00 , A61K38/55 , A61P7/02 , C07K1/14 , C07K14/435 , C07K14/81 , C12N15/09 , C12N15/15 , C12P21/02 , A61K38/57
Abstract: 2121246 9309231 PCTABS00022 The invention relates to a novel thrombin-inhibiting protein from ticks with a molecular weight of some 26000 Dalton and which has the amino acid partial sequences Val-Ala-Lys-Phe-Ala-X-Asn-Ser-Gly-Ser-Glu-Thr-Gly, His-Ala-Y-Phe-Glu, Arg-Val-Ser-Asp-Phe-Glu and Phe-Val-Tyr-Thr-Ile-Glu, in which X and Y may be the same or different and stand for a naturally occurring amino acid. The protein is suitable for combatting diseases.
-
公开(公告)号:MX9206339A
公开(公告)日:1993-05-01
申请号:MX9206339
申请日:1992-11-04
Applicant: BASF AG
Inventor: FRIEDRICH THOMAS , BIALOJAN SIEGFRIED , KROEGER BURKHARD , KUENAST CHRISTIPH
IPC: A61K35/64 , A61K38/00 , A61K38/55 , A61P7/02 , C07K14/00 , C07K14/245 , C07K14/435 , C07K14/81 , C12N15/15 , C12P21/02 , C12R1/19
Abstract: PCT No. PCT/EP92/02450 Sec. 371 Date Apr. 26, 1994 Sec. 102(e) Date Apr. 26, 1994 PCT Filed Oct. 27, 1992 PCT Pub. No. WO93/09232 PCT Pub. Date May 13, 1993.A novel thrombin-inhibitory protein from assassin bugs with a molecular weight of about 12,000 dalton and the N terminus Glu-Gly-Gly-Glu-Pro-Cys-Ala-Cys-Pro-His-Ala-Leu-His-Arg-Val-Cys-Gly-Ser-Asp is described. The protein is suitable for controlling diseases.
-
公开(公告)号:IN2599CH2006A
公开(公告)日:2007-06-08
申请号:IN2599CH2006
申请日:2006-07-17
Applicant: BASF AG
Inventor: KROEGER BURKHARD , ZELDER OSKAR , KLOPPROGGE CORINNA , SCHROEDER HARTWIG , HAEFNER STEFAN
Abstract: Use of a nucleic acid (I) with promoter activity for transcribing genes, where (I) is (a) a 173 nucleotide sequence (SEQ ID No.:1); (b) a variant of (SEQ ID No.:1) with at least 90% identity and derived by substitution, insertion or deletion of nucleotides; (c) a sequence that hybridizes to (SEQ ID No.:1) under stringent conditions; or (d) a functionally equivalent fragment of (a)-(c), is new. Independent claims are also included for: (1) use of an expression unit (EU), containing (I) and functionally linked to a sequence (X) that ensures translation of RNA, for expressing genes; (2) (I), other than sequence (SEQ ID No.:1), i.e. (Ia), as new compounds; (3) EU that contain (Ia) linked to (X); (4) altering (or producing) the transcription rate of genes in a microorganism, relative to the wild type; (5) expression cassette (EC) comprising at least one EU of (SEQ ID No.:1), at least one other nucleic acid sequence (to be expressed) and optionally additional gene control elements, where at least the first two are linked and the sequence being expressed is heterologous with respect to EU; (6) expression vector (EV) that contains EC; (7) genetically modified microorganisms (GMO) having, for at least one gene, an altered (or induced) transcription rate, relative to the wild type; (8) preparing biosynthetic products by culturing GMO of (7); (9) use of the sequence gaaagga (SEQ ID No.:44) as a ribosome-binding site in expression units that provide expression of genes in Corynebacterium or Brevibacterium; (10) use of the sequences tgcaat (SEQ ID No.:42) and tatcatt (SEQ ID No.:43) as -10 regionS for expression of genes in Corynebacterium or Brevibacterium; and (11) expression units that contain sequences (SEQ ID No.:42) - (SEQ ID No.:44).
-
-
-
-
-
-
-
-
-